Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
Philips X-Ray Table Recall Issued After Injuries Reported Manufacturer has issued additional instructions for using the Allura and Azurion systems following reports of multiple injuries. March 4, 2025 Darian Hauf Add Your Comments Federal health officials are alerting healthcare providers about an issue concerning Philips Allura and Azurion x-ray table systems after identifying situations that could lead to patients falling. The Philips Allura and Azurion systems are patient tables outfitted with x-ray imaging equipment. They are used in operating rooms to provide real-time visualization during minimally invasive procedures, helping doctors precisely place catheters and other medical devices. However, the U.S. Food and Drug Administration (FDA) announced a Philips Allura and Azurion systems alert on February 28, after receiving multiple reports of patient injuries caused by issues with mattress positioning and stability, which the agency warns can lead to potentially life-threatening injuries. Do You Know About… Childhood Diabetes Lawsuits Against Junk Food Industry Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… Childhood Diabetes Lawsuits Against Junk Food Industry Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods. Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to the recall, officials warn that patients may be at risk of falls and injuries due to mattresses slipping during transfers, improper positioning on the table, or the use of incorrect mattresses. These issues can lead to serious harm, including bruises, hematomas, skin abrasions, stiffness, hemorrhage, lacerations or even death. Philips has reported five injuries related to this issue, prompting the FDA to classify the recall as its most serious type. The recall includes the following operating room table systems: Allura CV20, Allura Xper FD10, Allura Xper FD10/10, Allura Xper FD10C, Allura Xper FD20, Allura Xper FD20 Biplane, Allura Xper FD20 Biplane OR Table, Allura Xper FD20 OR Table, Allura Xper FD20/10, Allura Xper FD20/20, Allura Xper FD20/15, Azurion 3 M12, Azurion 3 M15, Azurion 5 M12, Azurion 5 M20, Azurion 7 B12, Azurion 7 B20, Azurion 7 M12, Azurion 7 M20, Cardiovascular-Allura Centron. A complete list of affected Unique Device Identifiers (UDI), models, and lot/serial numbers for both the Allura system and the Azurion system is available on the FDA’s website. On January 13, Philips issued an Urgent Medical Device Correction letter to healthcare providers, advising them to follow updated mattress-use instructions and share the information with other users. The new guidelines emphasize: Safe patient transfers: Staff should communicate clearly about the patient’s weight and position. Proper mattress use: Ensure the correct mattress is fully supported by the table and that patients are carefully positioned to prevent slippage. Air plug adjustment: Open the mattress air plug to allow for proper expansion and contraction with the patient’s weight. Patient awareness: If a patient moves themselves onto the table, they should be informed that the mattress is not fixed. Philips is requesting that the response forms attached to letters be returned within 30 days of receipt and that any issues be reported to the customer’s local Philips representative at 1-800-722-9377. Customers in the U.S. with questions about this recall can also contact their local Philips representative at Philips Customer Care Solutions at 1-800-722-9377. Tags: Allura, Azurion, FDA, Philips, Recall, XRay Table More Stories Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use March 4, 2025 Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master March 4, 2025 Olympus Endoscope Guide Sheath Recall Issued After Multiple Injuries Following Tip Detachment March 4, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (Posted: today) A hair relaxer wrongful death lawsuit blames 16 years of using popular hair relaxer products like Just for Me and Dark & Lovely for the development of a fatal case of endometrial cancer. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025)Judge Indicates 40 Hair Relaxer Lawsuits Over Uterine Cancer, Endometrial Cancer and Ovarian Cancer Will Be Selected for Early Trial Program (02/03/2025)FDA Hair Relaxer Formaldehyde Ban Uncertain After All Pending Regulations Frozen: NBC Reports (01/24/2025) Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (Posted: yesterday) Judge is calling for Depo-Provera lawyers to submit applications for MDL leadership by the end of the week, indicating that female attorneys should be adequately represented. MORE ABOUT: DEPO-PROVERA LAWSUITJudge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025)Depo-Provera Lawyers Will Meet With MDL Judge For Initial Case Management Conference on Friday (02/18/2025)Side Effects of Combined Hormonal Contraceptives Carry Higher Blood Clot Risks Than Others: Study (02/18/2025) Oxbryta Injury Lawsuit Over Discontinued Sickle Cell Disease Drug Set for Trial in June 2027 (Posted: 4 days ago) A federal judge has scheduled an Oxbryta lawsuit to go before a jury on June 7, 2027, which may be the first trial over side effects of the discontinued sickle cell disease drug. MORE ABOUT: OXBRYTA LAWSUITOxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (12/30/2024)Lawsuit Alleges Oxbryta Side Effects Resulted in Higher Rate of Vaso-Occlusive Crisis, Other Debilitating Symptoms (11/19/2024)Oxbryta Recall Lawsuits Claim Drug Manufacturer Knew About Fatality Risks for Years (11/08/2024)
Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use March 4, 2025
Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master March 4, 2025
Olympus Endoscope Guide Sheath Recall Issued After Multiple Injuries Following Tip Detachment March 4, 2025
Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (Posted: today) A hair relaxer wrongful death lawsuit blames 16 years of using popular hair relaxer products like Just for Me and Dark & Lovely for the development of a fatal case of endometrial cancer. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025)Judge Indicates 40 Hair Relaxer Lawsuits Over Uterine Cancer, Endometrial Cancer and Ovarian Cancer Will Be Selected for Early Trial Program (02/03/2025)FDA Hair Relaxer Formaldehyde Ban Uncertain After All Pending Regulations Frozen: NBC Reports (01/24/2025)
Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (Posted: yesterday) Judge is calling for Depo-Provera lawyers to submit applications for MDL leadership by the end of the week, indicating that female attorneys should be adequately represented. MORE ABOUT: DEPO-PROVERA LAWSUITJudge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025)Depo-Provera Lawyers Will Meet With MDL Judge For Initial Case Management Conference on Friday (02/18/2025)Side Effects of Combined Hormonal Contraceptives Carry Higher Blood Clot Risks Than Others: Study (02/18/2025)
Oxbryta Injury Lawsuit Over Discontinued Sickle Cell Disease Drug Set for Trial in June 2027 (Posted: 4 days ago) A federal judge has scheduled an Oxbryta lawsuit to go before a jury on June 7, 2027, which may be the first trial over side effects of the discontinued sickle cell disease drug. MORE ABOUT: OXBRYTA LAWSUITOxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (12/30/2024)Lawsuit Alleges Oxbryta Side Effects Resulted in Higher Rate of Vaso-Occlusive Crisis, Other Debilitating Symptoms (11/19/2024)Oxbryta Recall Lawsuits Claim Drug Manufacturer Knew About Fatality Risks for Years (11/08/2024)